Not all selective estrogen response modulators are created equal: update on lasofoxifene.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Volumn 16 Suppl 2, Issue , 2006, Pages 504-

  Goldstein, S R ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS 1R (4' PYRROLIDINOETHOXYPHENYL) 2S PHENYL 6 HYDROXY 1,2,3,4 TETRAHYDRONAPHTHALENE, TARTRATE SALT; CIS-1R-(4'-PYRROLIDINOETHOXYPHENYL)-2S-PHENYL-6-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE, TARTRATE SALT; PYRROLIDINE DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TETRALIN DERIVATIVE;

ANIMAL; BONE DENSITY; BREAST TUMOR; DRUG EFFECT; FEMALE; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

ANIMALS; BONE DENSITY; BREAST NEOPLASMS; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PYRROLIDINES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TETRAHYDRONAPHTHALENES;

EID: 39049190092     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00681.x     Document Type: Review

References (17)